Research & Clinical Publications

Explore the clinical research behind Celestra Health. These studies show how smart insoles deliver accurate, real-world insight into gait, mobility, and disease progression.
AAN, 2026

Revolutionizing Gait Quality Monitoring in People with CIDP: An Instrumented Shoe Insole Solution

In collaboration with University of Ottawa, Duke University Medical Center and Sanofi.
This study explores how smart insoles can track gait quality in people with CIDP in real-world settings. It highlights how continuous monitoring can reduce clinic visits while improving disease tracking and care decisions.
Read Publication
AAN, 2026

Supervised Insole Gait Analysis in MS Clinical Practice: A Cost-Effective Alternative

In collaboration with the University of Ottawa and Technical University of Dresden (TUD).
This research shows how insole-based gait analysis can match traditional lab systems at a lower cost. It offers a practical way to bring accurate mobility assessment into everyday clinical use.
Read Publication
ISB, 2025

An Instrumented Shoe Insole Framework for Evaluating Healthy and Neurodegenerative Gait

In collaboration with the University of Ottawa.
This paper presents a full framework for analysing gait using wearable insoles across different populations. It shows strong accuracy and reliability compared to lab-based motion capture systems.
Read Publication
Pre-Print (medRxiv), 2025

Validation of an Instrumented Shoe Insole Framework for Analyzing Spatiotemporal Gait Metrics in Healthy and Neurodegenerative Populations

In collaboration with the University of Ottawa and the Ottawa Hospital Research Institute (OHRI).
This validation study confirms that insole-based systems can reliably measure detailed gait metrics. It supports their use for regular monitoring outside the clinic in real-life conditions.
Read Publication
ECTRIMS, 2025

Real-World Gait Monitoring in MS: A Smart Insole Framework for Data-Driven Gait Quality Assessments

In collaboration with the University of Ottawa, Ottawa Hospital Research Institute (OHRI) and Brigham and Women’s Hospital / Harvard Medical School.
This study shows how continuous gait monitoring can act as a digital biomarker for MS progression. It highlights the value of real-world data in understanding changes over time.
Read Publication
CMSC, 2025

Revolutionizing Gait Quality Monitoring in Multiple Sclerosis: An Instrumented Shoe Insole Solution

In collaboration with the University of Ottawa, Ottawa Hospital Research Institute (OHRI) and Brigham and Women’s Hospital / Harvard Medical School.
This research demonstrates how smart insoles can track gait quality and disease progression in MS. It focuses on using a single score to simplify complex clinical data.
Read Publication
ECTRIMS, 2023

Instrumented Shoe Insoles to Detect Changes in Gait Variability Across Disability Status in People with MS During a 500m Walk

In collaboration with the University of Ottawa.
This study shows how continuous gait monitoring can act as a digital biomarker for MS progression. It highlights the value of real-world data in understanding changes over time.
Read Publication
ECTRIMS, 2023

Identifying Gait Differences in MS Disability Status Using Instrumented Shoe Insoles

In collaboration with the University of Ottawa.
This research demonstrates how digital gait biomarkers can distinguish between different levels of MS disability. It supports the use of insoles for early detection and monitoring
Read Publication
ECTRIMS, 2023

Validation of an Instrumented Shoe Insole to Unobtrusively Monitor Gait Patterns

In collaboration with the University of Ottawa.
This study validates the accuracy of insole-based gait tracking against lab systems. It confirms that reliable clinical metrics can be captured during normal daily movement.
Read Publication
ECTRIMS, 2023

Gait Activity Recognition Using Instrumented Shoe Insoles in Persons With and Without Multiple Sclerosis.

In collaboration with the University of Ottawa.
This research uses machine learning to identify walking activities from insole data. It shows high accuracy in recognising movement types in both healthy people and MS patients.
Read Publication
Definitions:
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is the world's largest non-profit professional organization dedicated to the understanding, research, and treatment of Multiple Sclerosis (MS).

The American Academy of Neurologists (AAN) is the world's largest professional association for neurologists and neuroscience professionals, with over 44,000 members dedicated to promoting brain health, providing education, creating clinical practice guidelines, and improving patient care.

The Consortium of Multiple Sclerosis (CMSC) is the leading North American multidisciplinary organization for healthcare professionals and researchers dedicated to Multiple Sclerosis (MS) care and related demyelinating diseases.

The International Society of Biomechanics (ISB) is a global scientific organization that promotes the study and advancement of biomechanics: the study of the mechanics of biological systems through physics and engineering principles.

Pre-prints are non-peer reviewed versions of manuscripts posted to disseminate information to the research community prior to publication.

Publications are peer-reviewed manuscripts accepted by peers in the field. Manuscripts are hosted on the accepting journal’s webpage.

Revolutionizing walking analysis, one patient at a time

© Copyright 2025 - Celestra Health Systems - All Rights Reserved
Privacy PolicyTerms of Use
bookarrow-rightchevron-right-circle linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram